Welcome to the winter 2019 edition of US Respiratory & Pulmonary Diseases. We hope you will enjoy this interesting selection of articles. Editorial Board member Carolyn M D’Ambrosio introduces the issue, and asks readers to contribute to the winter 2020 edition. This edition features expert interviews with Scott Bickel on inhaled corticosteroid therapy and the impact of formulary changes on asthma control, Kevin Davidson on e-cigarettes and the outbreak on lipoid pneumonia in North Carolina, and Mary Cataletto on the concern around the use of electronic cigarettes among young people. We also include a review article on a combination therapy for Phe508del cystic fibrosis—elexacaftor-tezacaftor-ivacaftor, by Shinjing Jia and Jennifer L Taylor-Cousar. Finally, we have a case report by Casey Morris et al. on disseminated nocardiosis masquerading as an obstructive endobronchial mass.
We hope you enjoy reading the articles in this issue. If you are interested in submitting an article for the Winter 2020 edition, you can do so here.
Foreword–US Respiratory & Pulmonary Diseases. 2019;4(1):6
I am delighted to welcome you to the winter edition of US Respiratory & Pulmonary Diseases, where you will find a range of topical articles that we hope you find useful and relevant to your day-to-day clinical practice. We would like to take the opportunity to invite you to contribute to our winter 2020 edition. […]
Lessons from the Outbreak of E-cigarette-associated Lipoid Pneumonia in North Carolina
Q. What was previously known about the risks of e-cigarette use? E-cigarettes gained rapid popularity in the US after initial release in 2007. Although they were initially marketed towards smokers as a cessation aid, their use became swiftly prevalent with younger audiences including teenagers and young adults who had never previously smoked. In that timeline, […]
Inhaled Corticosteroid Therapy—The Impact of Formulary Changes on Asthma Control
Q. Why did Medicaid discontinue coverage of beclomethasone dipropionate in favor of mometasone furoate? A definitive reason for the change has not been divulged. Most formulary changes of this nature are done for economic reasons, the plan being able to acquire one drug at a lesser cost than another. These changes are quite common with […]
The Use of Sweetened and Flavored Electronic Cigarettes Among Young People—a Growing Concern
Q. How prevalent is the use of electronic cigarettes in children and adolescents? Based on the 2017 National Youth Survey published by the US Food and Drug Administration, 2.1 million American middle and high school students had used e-cigs in the past 30 days.1 E-cig use has surpassed the use of conventional tobacco cigarettes in […]
Elexacaftor-tezacaftor-ivacaftor—A Combination Therapy for Phe508del Cystic Fibrosis
Cystic fibrosis (CF), an inherited disease affecting all races and ethnicities, results from defects in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which leads to dysregulations in the ion and fluid balance across epithelial membranes throughout the body.1–3 The CFTR protein is an anion channel that functions as a transmembrane traffic ATPase which is […]
Disseminated Nocardiosis Masquerading as an Obstructive Endobronchial Mass—A Case Report
Highlights Nocardiosis is has been coined “the great imitator” due to the vast heterogeneity in clinical presentation. Prevalence of disease is on the rise due to improved diagnostic techniques, as well as a growing population of immunocompromised patients, although up to one-third of patients diagnosed are immunocompetent. There are six forms of disease caused […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!